期刊文献+

生物人工肾小管对β_2微球蛋白重吸收功能的研究 被引量:1

The Reabsorption of Beta2-Microglobulin by Filtration ThroughBioartificial Renal Tubule Assist Device in Vitro
下载PDF
导出
摘要 目的:探讨应用人肾近曲小管上皮细胞株(HK2)构建的生物人工肾小管辅助装置(RAD)体外对β2微球蛋白(β2-MG)的清除作用及机制。方法:A组以HK2体外培养后植入F60血液滤过器内腔构建的RAD后用含β2-MG的置换液体外模拟液体滤过,B组以上述条件构建的RAD用不含β2-MG的置换液模拟液体滤过,C组用含β2-MG的置换液对无细胞植入的F60滤器模拟液体滤过,对各组测定不同时间点的β2-MG滤过率,并应用免疫荧光法观察滤过后A、B组HK2细胞Megalin与β2-MG的蛋白表达。结果:A组β2-MG滤过率在各时间点均明显高于C组(P<0.05);C组β2-MG滤过率在第4h较同组前期各时间点明显降低(P<0.05)。免疫荧光显示A组Megalin与β2-MG同步表达,B组则仅见Megalin表达。结论:以HK2细胞构建的RAD可显著提高β2-MG的滤过率,其功能在4小时内可稳定维持,作用机制可能与Megalin的内吞作用相关。 Objective:To determine the clearance and mechanism of beta2-microglobulin(β2-MG) by using bioartificial renal tubule assist device(RAD) which constructed by HK2 cell line in vitro.Methods:HK2 cells were seeded into the hemofilter(F60) for constructing RAD,then the filtration in vitro was simulated by replacement fluids with β2-MG.RADs of group B were taken the filtration with replacement fluids without β2-MG.The hemofilters without HK2 cell line were uesd in filtration by replacement fluids with β2-MG as group C.The reabsorption rate of three groups were measured.The expression of megalin and β2-MG protein of group A and B were detected by immunofluorescence after filtration.Results:The β2-MG reabsorption rate of group A was significantly higher as compared with group C(P0.05).The reabsorption rate of β2-MG in group C at the fourth hour of filtration significantly decreased as compared with other time points of group C.Immunofluorescence detection indicated that HK2 cells of group A both have the expression of megalin and β2-MG,meanwhile only the expression of megalin was detected in the cells of group B.Conclusion:The RAD cuntructed by HK2 cell line can obviously increase the reabsorption function of β2-MG.The function could maintain well during 4 hours.The probable mechanism is associated with the endocytosis of megalin.
出处 《中国中西医结合肾病杂志》 2011年第3期205-207,I0002,共4页 Chinese Journal of Integrated Traditional and Western Nephrology
关键词 生物人工肾小管 Β2微球蛋白 Bioartificial renal tubule Beta2-microglobulin
  • 相关文献

参考文献8

  • 1Argiles A, Garcia - Garcia M, Derancourt J, et al. Beta 2 micro- globulin isoforms in healthy individuals and in amyloid deposits. Kidney Int, 1995,48 (5) : 1397 - 1405.
  • 2Cheung AK, Rocco MV, Yan G, et al. Serum β2 Microglobulin Levels Predict Mortality in Dialysis Patients: Results of the HEM O Study. J Am Soc Nephro1,2006,17 (2) :546 -555.
  • 3应旭旻,王笑云,沈霞.生物人工肾小管体外构建及对氨基酸、钠离子、肌酐转运功能的研究[J].中华肾脏病杂志,2004,20(2):118-121. 被引量:5
  • 4应旭旻,王笑云,沈霞.应用MTS方法检测生物人工肾小管的细胞活性[J].中国中西医结合肾病杂志,2006,7(2):72-74. 被引量:1
  • 5Raj DC, Ouwendyk M, Francoeur R, et al. β2 - Microglobulin ki- netics in nocturnal haemodialysis. Nephrol Dial Transplant, 2000,15 ( 1 ) :58 - 64.
  • 6Motoyoshi Y, Matsusaka T, Saito A, et al. Megalin contributes to the early injury of proximal tubule ceils during nonselective proteinuria. Kidney Int,200$ ,74(10) :1262 - 1269.
  • 7Odell RA, Slowiaczek P, Moran JE, et al. Beta2 - microglobulin kinetics in end- stage renal failure. Kidney Int, 1991,39 (5): 909 -919.
  • 8Ronco C, Canaud B, Aljama P. Clearance of Beta - 2 - micro- globulin and middle molecules in hemodiafiltration. Contrib Nephro1,2007,158 (2) :201 - 209.

二级参考文献10

  • 1应旭旻,王笑云,王恒进,毛慧娟,沈霞.生物人工肾小管对动物模型细胞因子水平及生存时间的影响[J].中国临床康复,2004,8(15):2866-2868. 被引量:4
  • 2Humes HD, MacKay SM, Funke AJ, et al. The bioartificial renal tubule assist device to enhance CRRT in acute renal failure. Am J Kidney Dis, 1997, S28-31:30-35.
  • 3Humes HD, MacKay SM, Funke A J, et al. Tissue engineering of a bioartificial renal tubule assist device: in vitro transport and metabolic characteristics. Kidney Int, 1999, 55: 2502-2514.
  • 4Humes HD. Bioartificial kidney for full renal replacement therapy. Semin Nephrol, 2000, 20:71-82.
  • 5Humes HD,MacKay SM,Funke AJ,et al.Tissue engineering of a bioartificial renal tubule assist device:in vitro transport and metabolic characteristics.Kidney Int,1999,55(6):2502-2514.
  • 6Vanholder R,Smet RD,Glorieux G,et al.Survival of hemodialysis patients and uremic toxin removal.Artif Organs,2003,27(3):218-223.
  • 7Kaplan AA.Extracorporeal blood purification in the treatment of acute renal failure with multiorgan involvement.Blood Purif,1996,14(1):86-93.
  • 8Humes HD,MacKay SM,Funke AJ,et al.The bioartificial renal tubule assist device to enhance CRRT in acute renal failure.Am J Kidney Dis,1997,30(Suppl 4):s28-s31.
  • 9应旭旻,王笑云,沈霞.生物人工肾小管体外构建的研究[J].南京医科大学学报(自然科学版),2001,21(3):263-265. 被引量:11
  • 10应旭旻,王笑云,沈霞.生物人工肾小管体外构建及对氨基酸、钠离子、肌酐转运功能的研究[J].中华肾脏病杂志,2004,20(2):118-121. 被引量:5

共引文献4

同被引文献29

  • 1黄扬扬.生物人工肾的研究进展[J].中国冶金工业医学杂志,2005,22(4):397-399. 被引量:4
  • 2朱文,柳慧琼,刘喜,等.一种具有生理功能的透析膜材料及其制备方法.中华人民共和国国家知识产权局,CN102366713A,2012.
  • 3唐丽萍,庞学丰,赖申昌,等.不同透析方式对患者透析充分性影响的研究[c]//北京:全国中西医结合发展战略研讨会,2011.162-163.
  • 4Teo JC, Ng RR, Ng CP, et al. Surface characteristics of a- crylic modified polysulfone membranes improves renal proximal tubule cell adhesion and spreading [J].Acta Biomaterialia, 2011, 7(5) : 2060-2069.
  • 5Piroddi M, Pilolli F, Aritomi M, et al. Vitamamin E as a functional and biocompatibility modifier of synthetic hemodia- lyzer membranes: an overview of the literature on vitamin E- modified hemodialyzer membranes [J].Am J Nephrol, 2012, 35(6) : 559-572.
  • 6Girndt M, Lengler S, Kaul H, et al. Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction[J]. Am J Kidney Dis, 2000, 35(1).. 95-104.
  • 7Nakamura T, Ushiyama C, Suzuki S, et al. PolymyxinB- im- mobilized fiber reduces increased plasma endothelin-1 concen- trations in hemodialysis patients with sepsis [J]. Ren Fail,2000, 22(2): 225-234.
  • 8Mahlicli FY, Altinkaya SA. The effects of urease immobiliza tion on the transport characteristics and protein adsorption ca- pacity of cellulose acetate based hemodialysis membranes [J].Journal of Materials Science-Materials in Medicine, 2009, 20 (10) .. 2167-2179.
  • 9Radhakumary C, Nair PD, Nair CPR, et al. Chitosan-graft- poly(vinyl acetate) for hemodialysis applications[J]. Journal of Applied Polymer Science, 2012, 125(3).. 2022-2033.
  • 10Palmer SC, Rabindranath KS, Craig JC, et al. High-flux ver- sus low-flux membranes for end-stage kidney disease [J]. Co- chrane Database Syst Rev, 2012 , 12;9: CD005016. doi: 10. 1002/14651858. CD005016. pub2.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部